PARTELLI, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 2.716
EU - Europa 2.167
AS - Asia 1.634
SA - Sud America 177
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 41
OC - Oceania 4
Totale 6.786
Nazione #
US - Stati Uniti d'America 2.640
RU - Federazione Russa 870
SG - Singapore 667
GB - Regno Unito 554
CN - Cina 476
IT - Italia 168
VN - Vietnam 146
BR - Brasile 138
HK - Hong Kong 133
DE - Germania 123
SE - Svezia 95
FR - Francia 91
FI - Finlandia 84
IE - Irlanda 79
KR - Corea 60
CA - Canada 41
BD - Bangladesh 36
UA - Ucraina 25
TR - Turchia 18
IN - India 17
MX - Messico 17
NL - Olanda 17
BE - Belgio 16
ID - Indonesia 16
AR - Argentina 15
NG - Nigeria 15
JP - Giappone 13
PL - Polonia 13
TG - Togo 9
ES - Italia 8
IQ - Iraq 8
AT - Austria 7
BJ - Benin 6
CL - Cile 6
PK - Pakistan 6
SA - Arabia Saudita 6
EC - Ecuador 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CZ - Repubblica Ceca 4
TT - Trinidad e Tobago 4
VE - Venezuela 4
ZA - Sudafrica 4
JM - Giamaica 3
KH - Cambogia 3
KZ - Kazakistan 3
LT - Lituania 3
OM - Oman 3
PE - Perù 3
RO - Romania 3
UY - Uruguay 3
BF - Burkina Faso 2
CO - Colombia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
KE - Kenya 2
LB - Libano 2
MA - Marocco 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
TH - Thailandia 2
BB - Barbados 1
BG - Bulgaria 1
CH - Svizzera 1
CY - Cipro 1
EG - Egitto 1
EU - Europa 1
GA - Gabon 1
GN - Guinea 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
IM - Isola di Man 1
IR - Iran 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
RE - Reunion 1
RS - Serbia 1
SV - El Salvador 1
SX - ???statistics.table.value.countryCode.SX??? 1
TN - Tunisia 1
Totale 6.747
Città #
Southend 473
Singapore 364
San Jose 322
Ashburn 304
Moscow 296
Jacksonville 215
Chandler 200
Woodbridge 160
Ann Arbor 151
Dallas 144
Hong Kong 132
Council Bluffs 92
Houston 85
Beijing 79
Dublin 79
Verona 72
New York 63
Ho Chi Minh City 52
The Dalles 52
Los Angeles 44
Wilmington 42
Lawrence 37
Princeton 37
Santa Clara 36
Jinan 30
Hanoi 27
Buffalo 24
Shenyang 21
Nanjing 20
Chicago 19
Helsinki 19
Munich 19
Milan 18
Redondo Beach 18
Sindelfingen 18
Hebei 17
Tianjin 17
Toronto 17
Brussels 16
Abuja 15
Changsha 14
Columbus 14
Guangzhou 14
London 14
Ningbo 14
Seoul 14
Atlanta 13
Da Nang 13
Nanchang 13
Orem 13
Stockholm 13
Tokyo 13
Brooklyn 12
Frankfurt am Main 12
Lancaster 12
San Francisco 12
São Paulo 12
Warsaw 12
Denver 11
Haikou 11
Amsterdam 10
Montreal 10
Zhengzhou 10
Jakarta 9
Lomé 9
Taizhou 9
Jiaxing 8
Mexico City 8
Bologna 7
Rome 7
Auburn Hills 6
Boardman 6
Cotonou 6
Hangzhou 6
Seattle 6
Shanghai 6
Ankara 5
Chennai 5
Fuzhou 5
Phoenix 5
Poplar 5
Rio de Janeiro 5
Taiyuan 5
Tashkent 5
Turku 5
Vienna 5
Barnet 4
Cagliari 4
Düsseldorf 4
Fortaleza 4
Grafing 4
Haiphong 4
Miami 4
Norwalk 4
Padova 4
Paris 4
Querétaro 4
Washington 4
Allentown 3
Baghdad 3
Totale 4.329
Nome #
Whole-genome landscape of pancreatic neuroendocrine tumours 294
Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas 242
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 215
Laparoscopic rectal resection for severe endometriosis of the mid and low rectum: technique and operative results. 193
Malignant pancreatic neuroendocrine tumour: Lymph node ratio and Ki67 are predictors of recurrence after curative resections 189
SILS cholecystectomy, early experience of a single institution: pilot study of 21 cases. 185
ASO Visual Abstract: Surgery for IPMN of the Pancreas—Preoperative Factors Tipping the Scale of Decision-Making 182
Incidental diagnosis as prognostic factor in different tumor stages of nonfunctioning pancreatic endocrine tumors 178
Partial Pancreaticoduodenectomy Can Provide Cure for Duodenal Gastrinoma Associated With Multiple Endocrine Neoplasia Type 1. 176
Parenchyma-sparing resections for pancreatic neoplasms. 171
Pancreatic Cystic Endocrine Tumors: A Different Morphological Entity Associated with a Less Aggressive Behavior. 170
Middle pancreatectomy: indications, short- and long-term operative outcomes. 168
Middle-preserving pancreatectomy for multicentric body-sparing lesions of the pancreas. 167
Surgical management of insulinomas: short- and long-term outcomes after enucleations and pancreatic resections. 166
Extent of surgical resections for intraductal papillary mucinous neoplasms. 165
Impact of lymphadenectomy on survival after surgery for sporadic gastrinoma. 161
Either High or low Risk: The Acinar Score at the Resection Margin Dichotomizes the Risk Spectrum Of Pancreas-specific Complications After Pancreatoduodenectomy 160
Intraductal papillary mucinous neoplasms of the pancreas with multifocal involvement of branch ducts 160
Implications of the new histological classification (WHO 2010) for pancreatic neuroendocrine neoplasms. 155
Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes. 154
Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy 154
OBSERVATIONAL STUDY OF NATURAL HISTORY OF SMALL SPORADIC NONFUNCTIONING PANCREATIC NEUROENDOCRINE TUMORS 149
Splenic Artery Invasion in Pancreatic Adenocarcinoma of the Body and Tail - a Novel Prognostic Parameter for Patients Selection 145
Middle-preserving pancreatectomy for multicentric body-sparing lesions of the pancreas. 144
Long-term outcomes and prognostic factors in neuroendocrine carcinomas of the pancreas: Morphology matters 144
Pleomorphic liposarcoma of the axilla metastatic to the pancreas. 142
Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. 138
Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio 138
Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours 137
Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-Making 136
Surgical treatment of pancreatic tumors in childhood and adolescence: uncommon neoplasms with favorable outcome. 136
Minimally invasive spleen-preserving distal pancreatectomy: real-world data from the Italian National Registry of Minimally Invasive Pancreatic Surgery (IGoMIPS) 118
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial 118
Pancreatic cystic tumours: when to resect, when to observe 118
Advanced Digestive Neuroendocrine Tumors: metastatic pattern is an independent factor affecting clinical outcome. 117
DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors 117
Rectal indomethacin to prevent post-ERCP pancreatitis. 116
Splenic Artery Invasion in Pancreatic Adenocarcinoma of the Body and Tail: A Novel Prognostic Parameter for Patient Selection 110
Author response to: Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours 106
Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors 106
Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms 104
Surgeon experience contributes to improved outcomes in pancreatoduodenectomies at high risk for fistula development 103
Study protocol for a multicenter randomized controlled trial to compare radiofrequency ablation with surgical resection for treatment of pancreatic insulinoma 100
Prospective minimally invasive pancreatic resections from the IGOMIPS registry: a snapshot of daily practice in Italy on 1191 between 2019 and 2022 93
The size of well differentiated pancreatic neuroendocrine tumors correlates with Ki67 proliferative index and is not associated with age 86
Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors 60
Totale 6.786
Categoria #
all - tutte 23.742
article - articoli 22.742
book - libri 0
conference - conferenze 525
curatela - curatele 0
other - altro 475
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.484


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022169 0 0 0 24 5 3 12 16 11 8 27 63
2022/2023556 50 52 70 77 39 123 14 40 65 2 16 8
2023/2024351 11 35 30 47 40 46 16 16 6 30 54 20
2024/2025907 52 45 23 171 55 28 53 31 141 56 90 162
2025/20262.857 198 107 149 482 761 183 314 129 231 167 56 80
2026/2027348 29 74 87 158 0 0 0 0 0 0 0 0
Totale 6.786